Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on RxSight, Maintains $22 Price Target

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

byBenzinga Newsdesk

March 7, 2023

1 minute read

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

Duluth’s Q4 Earnings Top Estimates; Clocks 3.7% Decline In Women’s Apparel Sales

By Shivani Kumaresan

Today, 11:04 PM

Duluth Holdings Inc (NASDAQ:DLTH) reported fourth-quarter FY21 sales growth of 5.8% year-on-year, to $270.76 million, beating the consensus of $268.45 million.…

DLTH

Morgan Stanley Maintains Equal-Weight on NOV, Raises Price Target to $19

By Benzinga Newsdesk

Today, 11:04 PM

Morgan Stanley analyst Connor Lynagh maintains NOV (NYSE:NOV) with a Equal-Weight and raises the price target from $18 to $19.

NOV

News

SVB Hired Goldman Sachs Group Earlier This Week To Execute A Private Stock Sale, With Plans To Announce It Upon Completion

By Benzinga Newsdesk

Today, 11:04 PM

-Wall Street Journal Report

News

Read What Telsey Advisory Analysts Think Of Costco’s December Sales

By Shivani Kumaresan

Today, 11:04 PM

Telsey Advisory Group analysts expect Costco Wholesale Corp’s (NASDAQ:COST) comparable sales for December 2021 to grow 13.7% versus 10.7% a year earlier. Analysts Joseph…

COST

Needham Reiterates Buy on RxSight, Maintains $22 Price Target

Related Posts

Duluth’s Q4 Earnings Top Estimates; Clocks 3.7% Decline In Women’s Apparel Sales

Morgan Stanley Maintains Equal-Weight on NOV, Raises Price Target to $19

SVB Hired Goldman Sachs Group Earlier This Week To Execute A Private Stock Sale, With Plans To Announce It Upon Completion

Read What Telsey Advisory Analysts Think Of Costco’s December Sales